American College Of Rheumatology

Despite the trials brought on by COVID-19, the American College of Rheumatology has “not slowed or stopped” but, instead, has continued to adapt to meet the challenges of the pandemic head-on, according to President David Karp, MD, PhD.

Data from an independent, prospective, observational registry reveals increased drug switching and less time spent on a given therapy among patients with rheumatoid arthritis from 2012 to 2015, according to researchers.

While the 2021 American College of Rheumatology rheumatoid arthritis recommendations improved over the 2015 document, understanding the weaknesses and limitations of the most recent iteration can be beneficial, according to a presenter here.

The American College of Rheumatology praised several aspects of a 2022 Medicare physician fee schedule proposed rule, including evaluation and management coding changes and the promise of greater telehealth flexibility.

The American College of Rheumatology has updated its COVID-19 vaccine clinical guidance for patients with rheumatic diseases to recommend a third dose of the mRNA vaccine in those receiving immunosuppressive or immunomodulatory therapy.

Maximizing the disease-modifying benefits of methotrexate is one of the core principles behind the 2021 American College of Rheumatology rheumatoid arthritis guidelines.

Demand for tocilizumab IV has outpaced the global supply, exacerbated by increased demand following the drug’s emergency use authorization for COVID-19 and the surge in delta variant cases, the American College of Rheumatology reported.

Contrary to Choosing Wisely recommendations, indiscriminate and high use of antinuclear antibodies multiplex testing has fostered widespread unfamiliarity of what it tests for and how to interpret its results, noted a presenter here.

CMS plans to rescind a Trump-era interim final rule that would have established a “most-favored nation” pricing model for Medicare Part B drugs, following months of lawsuits that saw the proposal stalled in federal court.

This past spring, two studies shed light on how some of the largest clinician organizations and publishers in rheumatology, including the American College of Rheumatology and EULAR, have failed to provide adequate training materials or clear guidelines when it comes to caring for patients of color.